Lytix Biopharma appoints Stephen Worsley as Chief Business Officer ...Middle East

OSLO, Norway, Sept. 5, 2022 /PRNewswire/ -- Lytix Biopharma ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces the appointment of Stephen Worsley as Chief Business Officer (CBO). Stephen Worsley is a pharmaceutical executive with over 25 years of...

Read More Details
Finally We wish PressBee provided you with enough information of ( Lytix Biopharma appoints Stephen Worsley as Chief Business Officer )

Also on site :

• ‘American Pickers’ Danielle Colby Makes Bold Declaration About Mike Wolfe Relationship
• Peter Weber Goes Public With His Relationship and His Family Has Thoughts
• Rachel Bilson Shares Rare Photo of Briar Rose, Her Daughter with Ex Hayden Christensen